Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer.

Kambiz RahbarAli Afshar-OromiehRobert SeifertStefan WagnerMichael SchäfersMartin BögemannMatthias Weckesser

Published in: European journal of nuclear medicine and molecular imaging (2018)

18F-PSMA-1007 PET/CT can detect recurrent PCa in a high percentage of patients with biochemical relapse. The probability of a pathological 18F-PSMA-1007 PET/CT scan seems to be high even in patients with a low PSA level ≤0.5 ng/ml, and this may have a significant impact on the management of this relevant group of patients.

Keyphrases

pet ct
prostate cancer
end stage renal disease
positron emission tomography
radical prostatectomy
newly diagnosed
ejection fraction
chronic kidney disease
computed tomography
peritoneal dialysis
prognostic factors
magnetic resonance imaging
magnetic resonance